{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:01:04Z","timestamp":1786370464369,"version":"build-2736575974"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00125-026-06779-2","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:59:06Z","timestamp":1782406746000},"page":"2534-2553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7336-7362","authenticated-orcid":false,"given":"Chiara","family":"Saponaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-4817","authenticated-orcid":false,"given":"Monica","family":"Imbernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8445-1157","authenticated-orcid":false,"given":"Isaline","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1721-1387","authenticated-orcid":false,"given":"Eleonora","family":"Deligia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3459-3138","authenticated-orcid":false,"given":"Shiqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4666-8395","authenticated-orcid":false,"given":"Iona","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2888-5456","authenticated-orcid":false,"given":"Ana","family":"Acosta-Montalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3499-8604","authenticated-orcid":false,"given":"Maria","family":"Moreno-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6680-5876","authenticated-orcid":false,"given":"Eve","family":"Wemelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6938-620X","authenticated-orcid":false,"given":"Lakshmi","family":"Kothegala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-5132","authenticated-orcid":false,"given":"Bego\u00f1a","family":"Porteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6195-3065","authenticated-orcid":false,"given":"Florent","family":"Auger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6214-4331","authenticated-orcid":false,"given":"Lorea","family":"Zubiaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5978-6959","authenticated-orcid":false,"given":"Nathalie","family":"Dellalau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6873-8640","authenticated-orcid":false,"given":"Julien","family":"Thevenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8323-7331","authenticated-orcid":false,"given":"Markus","family":"M\u00fchlemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6665-5825","authenticated-orcid":false,"given":"Gianni","family":"Pasquetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1236-359X","authenticated-orcid":false,"given":"Valery","family":"Gmyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7085-1431","authenticated-orcid":false,"given":"Frank W.","family":"Pfrieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-9930","authenticated-orcid":false,"given":"Ruben","family":"Nogueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-9718","authenticated-orcid":false,"given":"Markus","family":"Schwaninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7578-0767","authenticated-orcid":false,"given":"Patrik","family":"Rorsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3784-1503","authenticated-orcid":false,"given":"Bart","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7590-1896","authenticated-orcid":false,"given":"Julie","family":"Kerr-Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5213-5378","authenticated-orcid":false,"given":"Claude","family":"Knauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-2584","authenticated-orcid":false,"given":"Ben","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8388-3766","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Pattou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7185-3615","authenticated-orcid":false,"given":"Vincent","family":"Prevot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-8280","authenticated-orcid":false,"given":"Caroline","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"6779_CR1","doi-asserted-by":"publisher","first-page":"204201882098022","DOI":"10.1177\/2042018820980225","volume":"12","author":"C Baker","year":"2021","unstructured":"Baker C, Retzik-Stahr C, Singh V, Plomondon R, Anderson V, Rasouli N (2021) Should metformin remain the first-line therapy for treatment of type 2 diabetes? Ther Adv Endocrinol Metab 12:2042018820980225. https:\/\/doi.org\/10.1177\/2042018820980225","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"6779_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K et al (2015) A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med 373(1):11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1411892","journal-title":"N Engl J Med"},{"issue":"1","key":"6779_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/j.ajkd.2024.08.002","volume":"85","author":"MW Taal","year":"2025","unstructured":"Taal MW, Selby NM (2025) Glucagon-like peptide-1 receptor agonists: new evidence of kidney and cardiovascular protection from the FLOW and SELECT trials. Am J Kidney Dis 85(1):115\u2013118. https:\/\/doi.org\/10.1053\/j.ajkd.2024.08.002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"6779_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1463-1326.2012.01663.x","volume":"15","author":"AR Meloni","year":"2013","unstructured":"Meloni AR, DeYoung MB, Lowe C, Parkes DG (2013) GLP-1 receptor activated insulin secretion from pancreatic beta-cells: mechanism and glucose dependence. Diabetes Obes Metab 15(1):15\u201327. https:\/\/doi.org\/10.1111\/j.1463-1326.2012.01663.x","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"6779_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y et al (2024) Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther 9(1):234. https:\/\/doi.org\/10.1038\/s41392-024-01931-z","journal-title":"Signal Transduct Target Ther"},{"key":"6779_CR6","doi-asserted-by":"publisher","unstructured":"Zaborska KE, Jordan KL, Thorson AS et al (2022) Liraglutide increases islet Ca2+\u00a0oscillation frequency and insulin secretion by activating hyperpolarization-activated cyclic nucleotide-gated channels. Diabetes Obes Metab 24(9):1741\u20131752. https:\/\/doi.org\/10.1111\/dom.14747","DOI":"10.1111\/dom.14747"},{"key":"6779_CR7","doi-asserted-by":"publisher","first-page":"172594","DOI":"10.1016\/j.ejphar.2019.172594","volume":"861","author":"JY Zhou","year":"2019","unstructured":"Zhou JY, Poudel A, Welchko R et al (2019) Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways. Eur J Pharmacol 861:172594. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172594","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"6779_CR8","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.2337\/db17-1385","volume":"67","author":"JM Adams","year":"2018","unstructured":"Adams JM, Pei H, Sandoval DA et al (2018) Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons. Diabetes 67(8):1538\u20131548. https:\/\/doi.org\/10.2337\/db17-1385","journal-title":"Diabetes"},{"key":"6779_CR9","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.2337\/db14-0302","volume":"63","author":"D Beiroa","year":"2014","unstructured":"Beiroa D, Imbernon M, Gallego R et al (2014) GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes 63:3346\u20133358. https:\/\/doi.org\/10.2337\/db14-0302","journal-title":"Diabetes"},{"issue":"7","key":"6779_CR10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2022.06.002","volume":"34","author":"M Imbernon","year":"2022","unstructured":"Imbernon M, Saponaro C, Helms HCC et al (2022) Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions. Cell Metab 34(7):1054-1063 e1057. https:\/\/doi.org\/10.1016\/j.cmet.2022.06.002","journal-title":"Cell Metab"},{"key":"6779_CR11","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.2337\/db07-1824","volume":"57","author":"DA Sandoval","year":"2008","unstructured":"Sandoval DA, Bagnol D, Woods SC, D\u2019Alessio DA, Seeley RJ (2008) Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 57:2046\u20132054. https:\/\/doi.org\/10.2337\/db07-1824","journal-title":"Diabetes"},{"issue":"8","key":"6779_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/dom.12488","volume":"17","author":"E Tuduri","year":"2015","unstructured":"Tuduri E, Beiroa D, Porteiro B, Lopez M, Dieguez C, Nogueiras R (2015) Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice. Diabetes Obes Metab 17(8):789\u2013799. https:\/\/doi.org\/10.1111\/dom.12488","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"6779_CR13","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1038\/s41467-024-51076-4","volume":"15","author":"M Montaner","year":"2024","unstructured":"Montaner M, Denom J, Simon V et al (2024) A neuronal circuit driven by GLP-1 in the olfactory bulb regulates insulin secretion. Nat Commun 15(1):6941. https:\/\/doi.org\/10.1038\/s41467-024-51076-4","journal-title":"Nat Commun"},{"issue":"10","key":"6779_CR14","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1172\/JCI75276","volume":"124","author":"A Secher","year":"2014","unstructured":"Secher A, Jelsing J, Baquero AF et al (2014) The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J Clin Invest 124(10):4473\u20134488. https:\/\/doi.org\/10.1172\/JCI75276","journal-title":"J Clin Invest"},{"issue":"4","key":"6779_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cmet.2010.03.002","volume":"11","author":"JW Hill","year":"2010","unstructured":"Hill JW, Elias CF, Fukuda M et al (2010) Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab 11(4):286\u2013297. https:\/\/doi.org\/10.1016\/j.cmet.2010.03.002","journal-title":"Cell Metab"},{"issue":"6","key":"6779_CR16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2017.05.010","volume":"25","author":"S Ramirez","year":"2017","unstructured":"Ramirez S, Gomez-Valades AG, Schneeberger M et al (2017) Mitochondrial dynamics mediated by mitofusin 1 is required for POMC neuron glucose-sensing and insulin release control. Cell Metab 25(6):1390-1399 e1396. https:\/\/doi.org\/10.1016\/j.cmet.2017.05.010","journal-title":"Cell Metab"},{"issue":"18","key":"6779_CR17","doi-asserted-by":"publisher","first-page":"e140521","DOI":"10.1172\/jci140521","volume":"131","author":"T Lhomme","year":"2021","unstructured":"Lhomme T, Clasadonte J, Imbernon M et al (2021) Tanycytic networks mediate energy balance by feeding lactate to glucose-insensitive POMC neurons. J Clin Invest 131(18):e140521. https:\/\/doi.org\/10.1172\/jci140521","journal-title":"J Clin Invest"},{"issue":"11","key":"6779_CR18","doi-asserted-by":"publisher","first-page":"e3000680","DOI":"10.1371\/journal.pbio.3000680","volume":"18","author":"M Gervais","year":"2020","unstructured":"Gervais M, Labou\u00e8be G, Picard A, Thorens B, Croizier S (2020) EphrinB1 modulates glutamatergic inputs into POMC-expressing progenitors and controls glucose homeostasis. PLoS Biol 18(11):e3000680. https:\/\/doi.org\/10.1371\/journal.pbio.3000680","journal-title":"PLoS Biol"},{"issue":"6","key":"6779_CR19","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.celrep.2019.07.009","volume":"28","author":"C Saponaro","year":"2019","unstructured":"Saponaro C, Gmyr V, Thevenet J et al (2019) The GLP1R agonist liraglutide reduces hyperglucagonemia induced by the SGLT2 inhibitor dapagliflozin via somatostatin release. Cell Rep 28(6):1447-1454 e1444. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.009","journal-title":"Cell Rep"},{"issue":"16","key":"6779_CR20","doi-asserted-by":"publisher","first-page":"e129954","DOI":"10.1172\/jci.insight.129954","volume":"5","author":"ME Capozzi","year":"2019","unstructured":"Capozzi ME, Wait JB, Koech J et al (2019) Glucagon lowers glycemia when beta-cells are active. JCI Insight 5(16):e129954. https:\/\/doi.org\/10.1172\/jci.insight.129954","journal-title":"JCI Insight"},{"issue":"4","key":"6779_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cmet.2017.02.008","volume":"25","author":"AP Chambers","year":"2017","unstructured":"Chambers AP, Sorrell JE, Haller A et al (2017) The role of pancreatic preproglucagon in glucose homeostasis in mice. Cell Metab 25(4):927-934 e923. https:\/\/doi.org\/10.1016\/j.cmet.2017.02.008","journal-title":"Cell Metab"},{"issue":"52","key":"6779_CR22","doi-asserted-by":"publisher","first-page":"32810","DOI":"10.1074\/jbc.272.52.32810","volume":"272","author":"Y Rouille","year":"1997","unstructured":"Rouille Y, Kantengwa S, Irminger JC, Halban PA (1997) Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1. J Biol Chem 272(52):32810\u201332816. https:\/\/doi.org\/10.1074\/jbc.272.52.32810","journal-title":"J Biol Chem"},{"issue":"8","key":"6779_CR23","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1073\/pnas.91.8.3242","volume":"91","author":"Y Rouille","year":"1994","unstructured":"Rouille Y, Westermark G, Martin SK, Steiner DF (1994) Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc Natl Acad Sci U S A 91(8):3242\u20133246. https:\/\/doi.org\/10.1073\/pnas.91.8.3242","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6779_CR24","doi-asserted-by":"publisher","first-page":"e127994","DOI":"10.1172\/jci.insight.127994","volume":"5","author":"L Zhu","year":"2019","unstructured":"Zhu L, Dattaroy D, Pham J et al (2019) Intra-islet glucagon signaling is critical for maintaining glucose homeostasis. JCI Insight 5(10):e127994. https:\/\/doi.org\/10.1172\/jci.insight.127994","journal-title":"JCI Insight"},{"issue":"2","key":"6779_CR25","doi-asserted-by":"publisher","first-page":"e90093","DOI":"10.1371\/journal.pone.0090093","volume":"9","author":"S Piro","year":"2014","unstructured":"Piro S, Mascali LG, Urbano F et al (2014) Chronic exposure to GLP-1 increases GLP-1 synthesis and release in a pancreatic alpha cell line (alpha-TC1): evidence of a direct effect of GLP-1 on pancreatic alpha cells. PloS one 9(2):e90093. https:\/\/doi.org\/10.1371\/journal.pone.0090093","journal-title":"PloS one"},{"issue":"9","key":"6779_CR26","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1111\/dom.13353","volume":"20","author":"B Ahren","year":"2018","unstructured":"Ahren B, Atkin SL, Charpentier G et al (2018) Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials. Diabetes Obes Metab 20(9):2210\u20132219. https:\/\/doi.org\/10.1111\/dom.13353","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"6779_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(18)30024-X","volume":"6","author":"RE Pratley","year":"2018","unstructured":"Pratley RE, Aroda VR, Lingvay I et al (2018) Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. Lancet Diabetes Endocrinol 6(4):275\u2013286. https:\/\/doi.org\/10.1016\/S2213-8587(18)30024-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6779_CR28","doi-asserted-by":"publisher","first-page":"120636","DOI":"10.1016\/j.lfs.2022.120636","volume":"301","author":"GO de Souza","year":"2022","unstructured":"de Souza GO, Wasinski F, Donato J Jr (2022) Characterization of the metabolic differences between male and female C57BL\/6 mice. Life Sci 301:120636. https:\/\/doi.org\/10.1016\/j.lfs.2022.120636","journal-title":"Life Sci"},{"key":"6779_CR29","doi-asserted-by":"publisher","unstructured":"John WG, Diabetes UKDoHACo (2012) Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011. Diabet Med 29(11):1350\u20131357. https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03762.x","DOI":"10.1111\/j.1464-5491.2012.03762.x"},{"key":"6779_CR30","doi-asserted-by":"publisher","first-page":"963689725135065","DOI":"10.1177\/09636897251350654","volume":"34","author":"P Gnanasekar","year":"2025","unstructured":"Gnanasekar P, Saponaro C, Muhlemann M et al (2025) Standardized dynamic glucose testing reveals donor-dependent heterogeneity in human islet function. Cell Transplant 34:9636897251350654. https:\/\/doi.org\/10.1177\/09636897251350654","journal-title":"Cell Transplant"},{"issue":"3","key":"6779_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.neuron.2012.03.027","volume":"74","author":"M Slezak","year":"2012","unstructured":"Slezak M, Grosche A, Niemiec A et al (2012) Relevance of exocytotic glutamate release from retinal glia. Neuron 74(3):504\u2013516. https:\/\/doi.org\/10.1016\/j.neuron.2012.03.027","journal-title":"Neuron"},{"key":"6779_CR32","doi-asserted-by":"publisher","first-page":"101996","DOI":"10.1016\/j.molmet.2024.101996","volume":"87","author":"M Duquenne","year":"2024","unstructured":"Duquenne M, Deligia E, Folgueira C et al (2024) Tanycytic transcytosis inhibition disrupts energy balance, glucose homeostasis and cognitive function in male mice. Mol Metab 87:101996. https:\/\/doi.org\/10.1016\/j.molmet.2024.101996","journal-title":"Mol Metab"},{"issue":"13","key":"6779_CR33","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1113\/jp275934","volume":"596","author":"M Sala-Rabanal","year":"2018","unstructured":"Sala-Rabanal M, Ghezzi C, Hirayama BA et al (2018) Intestinal absorption of glucose in mice as determined by positron emission tomography. J Physiol 596(13):2473\u20132489. https:\/\/doi.org\/10.1113\/jp275934","journal-title":"J Physiol"},{"issue":"6","key":"6779_CR34","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/gutjnl-2019-320230","volume":"70","author":"A Abot","year":"2021","unstructured":"Abot A, Wemelle E, Laurens C et al (2021) Identification of new enterosynes using prebiotics: roles of bioactive lipids and mu-opioid receptor signalling in humans and mice. Gut 70(6):1078\u20131087. https:\/\/doi.org\/10.1136\/gutjnl-2019-320230","journal-title":"Gut"},{"issue":"6","key":"6779_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40262-015-0343-6","volume":"55","author":"LV Jacobsen","year":"2016","unstructured":"Jacobsen LV, Flint A, Olsen AK, Ingwersen SH (2016) Liraglutide in type 2 diabetes mellitus: clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 55(6):657\u2013672. https:\/\/doi.org\/10.1007\/s40262-015-0343-6","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"6779_CR36","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2337\/dca24-0034","volume":"47","author":"A Jullien","year":"2024","unstructured":"Jullien A, Jambon-Barbara C, Cracowski JL et al (2024) Regional heterogeneity of the results of glucagon-like peptide 1 receptor agonist trials in type 2 diabetes: a reanalysis of individual participant data. Diabetes Care 47(11):1949\u20131957. https:\/\/doi.org\/10.2337\/dca24-0034","journal-title":"Diabetes Care"},{"key":"6779_CR37","doi-asserted-by":"publisher","first-page":"175107","DOI":"10.1016\/j.ejphar.2022.175107","volume":"928","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhang Y, Peng X et al (2022) GZR18, a novel long-acting GLP-1 analog, demonstrated positive in vitro and in vivo pharmacokinetic and pharmacodynamic characteristics in animal models. Eur J Pharmacol 928:175107. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175107","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"6779_CR38","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1172\/JCI81975","volume":"125","author":"M Shigeto","year":"2015","unstructured":"Shigeto M, Ramracheya R, Tarasov AI et al (2015) GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation. J Clin Invest 125(12):4714\u20134728. https:\/\/doi.org\/10.1172\/JCI81975","journal-title":"J Clin Invest"},{"issue":"12","key":"6779_CR39","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.1172\/JCI140046","volume":"130","author":"OS Oduori","year":"2020","unstructured":"Oduori OS, Murao N, Shimomura K et al (2020) Gs\/Gq signaling switch in \u03b2 cells defines incretin effectiveness in diabetes. J Clin Invest 130(12):6639\u20136655. https:\/\/doi.org\/10.1172\/JCI140046","journal-title":"J Clin Invest"},{"key":"6779_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-90-481-3271-3_12","volume":"654","author":"R Bertram","year":"2010","unstructured":"Bertram R, Sherman A, Satin LS (2010) Electrical bursting, calcium oscillations, and synchronization of pancreatic islets. Adv Exp Med Biol 654:261\u2013279. https:\/\/doi.org\/10.1007\/978-90-481-3271-3_12","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"6779_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/diabetes.53.1.5","volume":"53","author":"GG Holz","year":"2004","unstructured":"Holz GG (2004) Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 53(1):5\u201313. https:\/\/doi.org\/10.2337\/diabetes.53.1.5","journal-title":"Diabetes"},{"key":"6779_CR42","doi-asserted-by":"publisher","unstructured":"Kang G, Joseph JW, Chepurny OG et al (2003) Epac-selective cAMP analog 8-pCPT-2\u2019-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells. J Biol Chem 278(10):8279\u20138285. https:\/\/doi.org\/10.1074\/jbc.M211682200","DOI":"10.1074\/jbc.M211682200"},{"issue":"9","key":"6779_CR43","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00125-014-3299-4","volume":"57","author":"BA Omar","year":"2014","unstructured":"Omar BA, Liehua L, Yamada Y, Seino Y, Marchetti P, Ahren B (2014) Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes. Diabetologia 57(9):1876\u20131883. https:\/\/doi.org\/10.1007\/s00125-014-3299-4","journal-title":"Diabetologia"},{"issue":"3","key":"6779_CR44","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00125-023-06060-w","volume":"67","author":"NR Gandasi","year":"2024","unstructured":"Gandasi NR, Gao R, Kothegala L et al (2024) GLP-1 metabolite GLP-1(9\u201336) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion. Diabetologia 67(3):528\u2013546. https:\/\/doi.org\/10.1007\/s00125-023-06060-w","journal-title":"Diabetologia"},{"issue":"7","key":"6779_CR45","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/oby.2008.229","volume":"16","author":"D Elahi","year":"2008","unstructured":"Elahi D, Egan JM, Shannon RP et al (2008) GLP-1 (9\u201336) amide, cleavage product of GLP-1 (7\u201336) amide, is a glucoregulatory peptide. Obesity (Silver Spring) 16(7):1501\u20131509. https:\/\/doi.org\/10.1038\/oby.2008.229","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"6779_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/JOE-17-0263","volume":"234","author":"P Millar","year":"2017","unstructured":"Millar P, Pathak N, Parthsarathy V et al (2017) Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice. J Endocrinol 234(3):255\u2013267. https:\/\/doi.org\/10.1530\/JOE-17-0263","journal-title":"J Endocrinol"},{"issue":"8","key":"6779_CR47","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s42255-021-00432-5","volume":"3","author":"M Duquenne","year":"2021","unstructured":"Duquenne M, Folgueira C, Bourouh C et al (2021) Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function. Nat Metab 3(8):1071\u20131090. https:\/\/doi.org\/10.1038\/s42255-021-00432-5","journal-title":"Nat Metab"},{"issue":"1","key":"6779_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1758-5996-6-3","volume":"6","author":"L Fransson","year":"2014","unstructured":"Fransson L, Dos Santos C, Wolbert P, Sjoholm A, Rafacho A, Ortsater H (2014) Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome. Diabetol Metab Syndr 6(1):3. https:\/\/doi.org\/10.1186\/1758-5996-6-3","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"6779_CR49","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1210\/en.2012-1165","volume":"153","author":"J Shirakawa","year":"2012","unstructured":"Shirakawa J, Tanami R, Togashi Y et al (2012) Effects of liraglutide on beta-cell-specific glucokinase-deficient neonatal mice. Endocrinology 153(7):3066\u20133075. https:\/\/doi.org\/10.1210\/en.2012-1165","journal-title":"Endocrinology"},{"issue":"1","key":"6779_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3803\/EnM.2020.781","volume":"36","author":"JH Kim","year":"2021","unstructured":"Kim JH, Lee GY, Maeng HJ et al (2021) Effects of glucagon-like peptide-1 analogue and fibroblast growth factor 21 combination on the atherosclerosis-related process in a type 2 diabetes mouse model. Endocrinol Metab (Seoul) 36(1):157\u2013170. https:\/\/doi.org\/10.3803\/EnM.2020.781","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"7","key":"6779_CR51","doi-asserted-by":"publisher","first-page":"e39887","DOI":"10.1371\/journal.pone.0039887","volume":"7","author":"G Mazzuoli","year":"2012","unstructured":"Mazzuoli G, Schemann M (2012) Mechanosensitive enteric neurons in the myenteric plexus of the mouse intestine. PloS one 7(7):e39887. https:\/\/doi.org\/10.1371\/journal.pone.0039887","journal-title":"PloS one"},{"key":"6779_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.05.002","author":"D Borgmann","year":"2021","unstructured":"Borgmann D, Ciglieri E, Biglari N et al (2021) Gut-brain communication by distinct sensory neurons differently controls feeding and glucose metabolism. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.002","journal-title":"Cell Metab"},{"issue":"4","key":"6779_CR53","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA Defronzo","year":"2009","unstructured":"Defronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58(4):773\u2013795. https:\/\/doi.org\/10.2337\/db09-9028","journal-title":"Diabetes"},{"issue":"9922","key":"6779_CR54","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet (London, England) 383(9922):1068\u20131083. https:\/\/doi.org\/10.1016\/S0140-6736(13)62154-6","journal-title":"Lancet (London, England)"},{"issue":"7121","key":"6779_CR55","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121):840\u2013846. https:\/\/doi.org\/10.1038\/nature05482","journal-title":"Nature"},{"issue":"37","key":"6779_CR56","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1073\/pnas.1006639107","volume":"107","author":"RH Unger","year":"2010","unstructured":"Unger RH, Orci L (2010) Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci U S A 107(37):16009\u201316012. https:\/\/doi.org\/10.1073\/pnas.1006639107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"6779_CR57","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","volume":"42","author":"SE Kahn","year":"1993","unstructured":"Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42(11):1663\u20131672. https:\/\/doi.org\/10.2337\/diab.42.11.1663","journal-title":"Diabetes"},{"issue":"6","key":"6779_CR58","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","volume":"150","author":"C Talchai","year":"2012","unstructured":"Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150(6):1223\u20131234. https:\/\/doi.org\/10.1016\/j.cell.2012.07.029","journal-title":"Cell"},{"issue":"11","key":"6779_CR59","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","volume":"140","author":"L Hansen","year":"1999","unstructured":"Hansen L, Deacon CF, Orskov C, Holst JJ (1999) Glucagon-like peptide-1-(7\u201336)amide is transformed to glucagon-like peptide-1-(9\u201336)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140(11):5356\u20135363. https:\/\/doi.org\/10.1210\/endo.140.11.7143","journal-title":"Endocrinology"},{"issue":"4","key":"6779_CR60","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87(4):1409\u20131439. https:\/\/doi.org\/10.1152\/physrev.00034.2006","journal-title":"Physiol Rev"},{"issue":"11","key":"6779_CR61","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1111\/dom.14794","volume":"24","author":"B Jones","year":"2022","unstructured":"Jones B, Burade V, Akalestou E et al (2022) In vivo and in vitro characterization of GL0034, a novel long-acting glucagon-like peptide-1 receptor agonist. Diabetes Obes Metab 24(11):2090\u20132101. https:\/\/doi.org\/10.1111\/dom.14794","journal-title":"Diabetes Obes Metab"},{"key":"6779_CR62","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fphys.2019.00930","volume":"10","author":"L Ren","year":"2019","unstructured":"Ren L, Cui Q, Liu W et al (2019) Novel GLP-1 analog supaglutide stimulates insulin secretion in mouse and human islet beta-cells and improves glucose homeostasis in diabetic mice. Front Physiol 10:930. https:\/\/doi.org\/10.3389\/fphys.2019.00930","journal-title":"Front Physiol"},{"issue":"7","key":"6779_CR63","doi-asserted-by":"publisher","first-page":"e6221","DOI":"10.1371\/journal.pone.0006221","volume":"4","author":"ML Peyot","year":"2009","unstructured":"Peyot ML, Gray JP, Lamontagne J et al (2009) Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells. PloS One 4(7):e6221. https:\/\/doi.org\/10.1371\/journal.pone.0006221","journal-title":"PloS One"},{"key":"6779_CR64","doi-asserted-by":"publisher","first-page":"114917","DOI":"10.1016\/j.physbeh.2025.114917","volume":"296","author":"R Dali","year":"2025","unstructured":"Dali R, Langlet F (2025) Tanycytes in the nexus of hypothalamic inflammation, appetite control, and obesity. Physiol Behav 296:114917. https:\/\/doi.org\/10.1016\/j.physbeh.2025.114917","journal-title":"Physiol Behav"},{"issue":"7","key":"6779_CR65","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1007\/s11033-013-2546-y","volume":"40","author":"RA Ribeiro","year":"2013","unstructured":"Ribeiro RA, Balbo SL, Roma LP et al (2013) Impaired muscarinic type 3 (M3) receptor\/PKC and PKA pathways in islets from MSG-obese rats. Mol Biol Rep 40(7):4521\u20134528. https:\/\/doi.org\/10.1007\/s11033-013-2546-y","journal-title":"Mol Biol Rep"},{"issue":"2","key":"6779_CR66","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2337\/diabetes.51.2.424","volume":"51","author":"CB Juhl","year":"2002","unstructured":"Juhl CB, Hollingdal M, Sturis J et al (2002) Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. Diabetes 51(2):424\u2013429. https:\/\/doi.org\/10.2337\/diabetes.51.2.424","journal-title":"Diabetes"},{"issue":"2","key":"6779_CR67","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2015.08.038","volume":"64","author":"MJ Armstrong","year":"2016","unstructured":"Armstrong MJ, Hull D, Guo K et al (2016) Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis. J Hepatol 64(2):399\u2013408. https:\/\/doi.org\/10.1016\/j.jhep.2015.08.038","journal-title":"J Hepatol"},{"issue":"Suppl 1(0 1)","key":"6779_CR68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/dom.12332","volume":"16","author":"JM Rojas","year":"2014","unstructured":"Rojas JM, Schwartz MW (2014) Control of hepatic glucose metabolism by islet and brain. Diabetes Obes Metab 16(Suppl 1(0 1)):33\u201340. https:\/\/doi.org\/10.1111\/dom.12332","journal-title":"Diabetes Obes Metab"},{"key":"6779_CR69","doi-asserted-by":"publisher","unstructured":"Armstrong M, Hull D, Guo K, et al (2014) Effect of liraglutide on adipose insulin resistance and hepatic de-novo lipogenesis in non-alcoholic steatohepatitis: substudy of a phase 2, randomised placebo-controlled trial. Lancet 383(Special Issue S21). https:\/\/doi.org\/10.1016\/S0140-6736(14)60284-1","DOI":"10.1016\/S0140-6736(14)60284-1"},{"issue":"1","key":"6779_CR70","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00125-012-2738-3","volume":"56","author":"M Seghieri","year":"2013","unstructured":"Seghieri M, Rebelos E, Gastaldelli A et al (2013) Direct effect of GLP-1 infusion on endogenous glucose production in humans. Diabetologia 56(1):156\u2013161. https:\/\/doi.org\/10.1007\/s00125-012-2738-3","journal-title":"Diabetologia"},{"issue":"1","key":"6779_CR71","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00018-024-05507-6","volume":"81","author":"N da Silva Lima","year":"2024","unstructured":"da Silva Lima N, Cabaleiro A, Novoa E et al (2024) GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cells. Cell Mol Life Sci 81(1):468. https:\/\/doi.org\/10.1007\/s00018-024-05507-6","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"6779_CR72","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cmet.2012.09.005","volume":"16","author":"BM Filippi","year":"2012","unstructured":"Filippi BM, Yang CS, Tang C, Lam TK (2012) Insulin activates Erk1\/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab 16(4):500\u2013510. https:\/\/doi.org\/10.1016\/j.cmet.2012.09.005","journal-title":"Cell Metab"},{"issue":"12","key":"6779_CR73","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/nm798","volume":"8","author":"S Obici","year":"2002","unstructured":"Obici S, Zhang BB, Karkanias G, Rossetti L (2002) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8(12):1376\u20131382. https:\/\/doi.org\/10.1038\/nm798","journal-title":"Nat Med"},{"issue":"2","key":"6779_CR74","doi-asserted-by":"publisher","first-page":"e2609","DOI":"10.1038\/cddis.2017.28","volume":"8","author":"M Yang","year":"2017","unstructured":"Yang M, Wang J, Wu S et al (2017) Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-delta-dependent neurocircuitry. Cell Death Dis 8(2):e2609. https:\/\/doi.org\/10.1038\/cddis.2017.28","journal-title":"Cell Death Dis"},{"issue":"10","key":"6779_CR75","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2337\/diabetes.49.10.1635","volume":"49","author":"R Burcelin","year":"2000","unstructured":"Burcelin R, Dolci W, Thorens B (2000) Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49(10):1635\u20131642. https:\/\/doi.org\/10.2337\/diabetes.49.10.1635","journal-title":"Diabetes"},{"issue":"8","key":"6779_CR76","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.2337\/diabetes.50.8.1720","volume":"50","author":"R Burcelin","year":"2001","unstructured":"Burcelin R, Da Costa A, Drucker D, Thorens B (2001) Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 50(8):1720\u20131728. https:\/\/doi.org\/10.2337\/diabetes.50.8.1720","journal-title":"Diabetes"},{"key":"6779_CR77","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molmet.2018.01.020","volume":"10","author":"A Abot","year":"2018","unstructured":"Abot A, Lucas A, Bautzova T et al (2018) Galanin enhances systemic glucose metabolism through enteric nitric oxide synthase-expressed neurons. Mol Metab 10:100\u2013108. https:\/\/doi.org\/10.1016\/j.molmet.2018.01.020","journal-title":"Mol Metab"},{"issue":"33","key":"6779_CR78","doi-asserted-by":"publisher","first-page":"11529","DOI":"10.1074\/jbc.RA120.014368","volume":"295","author":"SM Gray","year":"2020","unstructured":"Gray SM, Xin Y, Ross EC et al (2020) Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells. J Biol Chem 295(33):11529\u201311541. https:\/\/doi.org\/10.1074\/jbc.RA120.014368","journal-title":"J Biol Chem"},{"key":"6779_CR79","doi-asserted-by":"publisher","first-page":"116965","DOI":"10.1016\/j.biopha.2024.116965","volume":"177","author":"J Sun","year":"2024","unstructured":"Sun J, Xiao Y, Xing W et al (2024) Pharmacodynamic and pharmacokinetic profiles of a novel GLP-1 receptor biased agonist-SAL0112. Biomed Pharmacother 177:116965. https:\/\/doi.org\/10.1016\/j.biopha.2024.116965","journal-title":"Biomed Pharmacother"},{"issue":"Suppl 3","key":"6779_CR80","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.2337\/diabetes.53.suppl_3.s205","volume":"53","author":"LL Baggio","year":"2004","unstructured":"Baggio LL, Kim JG, Drucker DJ (2004) Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo. Diabetes 53(Suppl 3):S205-214. https:\/\/doi.org\/10.2337\/diabetes.53.suppl_3.s205","journal-title":"Diabetes"},{"key":"6779_CR81","doi-asserted-by":"publisher","unstructured":"Sauv\u00e9 F, Martinez-G\u00f3mez R, Mbouamboua Y et al Tanycytic degeneration impairs tau clearance and contributes to Alzheimer\u2019s disease pathology. Cell Press Blue. https:\/\/doi.org\/10.1016\/j.cpblue.2026.100003","DOI":"10.1016\/j.cpblue.2026.100003"},{"key":"6779_CR82","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/B978-0-444-53491-0.00023-7","volume":"117","author":"PE Cryer","year":"2013","unstructured":"Cryer PE (2013) Hypoglycemia-associated autonomic failure in diabetes. Handb Clin Neurol 117:295\u2013307. https:\/\/doi.org\/10.1016\/B978-0-444-53491-0.00023-7","journal-title":"Handb Clin Neurol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06779-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:22:46Z","timestamp":1786368166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-026-06779-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["6779"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06779-2","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The Electronic Supplementary Material was corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by the European Foundation for the Study of Diabetes\/Lilly-2016 (to C. Bonner), the Soci\u00e9t\u00e9 Francophone du Diab\u00e8te 2015 (to C. Bonner), the Conseil Regional Nord-Pas de Calais (to C. Bonner), the European Consortium for Islet Transplantation funded by the Juvenile Diabetes Research Foundation (to J. Kerr-Conte and F. Pattou), European Genomic Institute for Diabetes grant ANR-10-LABX-0046 (to V. Prevot, F. Pattou and B. Staels), I-SITE ULNE grant ANR-16-IDEX-0004 (to V. Prevot, F. Pattou and B. Staels), European Research Council Synergy Grant 810331 (to V. Prevot, R. Nogueiras and M. Schwaninger), Agence National de la Recherche Grant ANR-15-CE14-0025 (to V. Prevot), Novo Nordisk A\/S (to V. Prevot), H2020-MSCA Grant 748134 (to M. Imbernon), Agence Nationale de la Recherche Grant ANR-18-CE14-0007-01 ENDIABAC (to C. Knauf), the International Research Project Grant NeuroMicrobiota from Inserm (to C. Knauf), Medical Research Council grant MR\/R010676\/1 (to B. Jones), Diabetes UK grant 20\/0006307 (to B. Jones) and the Imperial College London IPPRF scheme (to B. Jones). The Section of Endocrinology and Investigative Medicine at Imperial College London is supported by the NIHR Biomedical Research Centre Funding Scheme and the NIHR\/Imperial Clinical Research Facility. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. We thank the islet isolation team at Lille University Hospital for providing human islets and acknowledge the technical assistance from the imaging core facility at Imperial College London.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All data generated or analysed during this study are included in the published article and its supplementary information files. Additional raw data, analytical methods and study materials are available from the corresponding authors upon reasonable request for 10 years after the publication of the data. Mouse models described in this study are available through material transfer agreements with the originating institutions. There will be no restriction to data sharing following publication, other than the necessary anonymisation of human data.","order":2,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"CK is a co-founder of Enterosys SA (Lab\u00e8ge, France). All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"CS, MI, VP and CB conceptualised and supervised the study. CS, MI, IL, ED, SC, ID, AA-M, MM-L, EW, LK, BP, FA, LZ, ND, JT, MM, GP, VG, FWP, RN, MS, PR, BS, JK-C, CK, BJ, FP, VP and CB contributed to the conception or design of the work, data acquisition, analysis or interpretation of data. All authors drafted the article or reviewed it critically for important intellectual content. All authors approved the final version of the manuscript. CB and VP are the guarantors of this work and, as such, had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.","order":4,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}